GHK-Cu FAQ: 22 questions, answered from the literature

What is the neuroprotective research on GHK-Cu?

GHK (the free tripeptide) prevented copper- and zinc-induced protein aggregation and CNS cell death in vitro by sequestering extracellular copper ^[10]. Intranasal GHK improved spatial memory in aged and 5xFAD Alzheimer-model mice and reduced amyloid and neuroinflammation markers ^[8][13]. Gene-expression analyses report upregulation of neuron-associated genes ^[2]. All of this evidence is preclinical, and the mouse cognition studies are bioRxiv preprints.

Can GHK-Cu cross the blood-brain barrier?

No validated human blood-brain-barrier penetration data exists. The rodent neuroprotection studies delivered GHK intranasally at 15 mg/kg ^[8][13], a route that can bypass the blood-brain barrier for nose-to-brain transport; in vitro neuronal work added the peptide directly to cell cultures ^[10]. Systemic central exposure in humans has not been established.

Does copper help hair growth?

In a 6-month trial of 45 men with androgenetic alopecia, a 5-aminolevulinic-acid + glycyl-histidyl-lysine complex (ALAVAX) increased hair count significantly versus placebo ^[4]. Tissue-remodeling reviews attribute copper-peptide hair effects to VEGF and FGF-2 upregulation and follicle angiogenesis rather than hormone blockade ^[6].

What does a GHK-Cu peptide do?

GHK-Cu is a copper-binding tripeptide that stimulates fibroblast synthesis of collagen, elastin, glycosaminoglycans, and decorin, supports wound repair and angiogenesis via VEGF and FGF-2, and modulates a broad set of repair, antioxidant, and DNA-repair genes in study models ^[2][3][6]. It acts at picomolar-to-nanomolar concentrations as a signal, not as a bulk nutrient or building block.

What is GHK-Cu and how does it work?

GHK-Cu is the glycyl-L-histidyl-L-lysine copper(II) complex, present endogenously in human plasma. It acts as a copper chaperone and a pleiotropic signaling molecule, rebalancing matrix metalloproteinases against their TIMP inhibitors and engaging TGF-beta, NF-kB-suppressing, and Nrf2 antioxidant pathways ^[3][6]. In fibroblasts, collagen synthesis begins near 10^-12 M, marking it as a high-potency signal ^[1].

Is GHK-Cu peptide really anti-aging?

Plasma GHK declines from about 200 ng/mL at age 20 to about 80 ng/mL by age 60, and topical GHK-Cu increased procollagen in 70% of treated subjects versus 40% for retinoic acid in reviewed trials ^[3][9]. Gene-expression analyses report shifts toward repair and antioxidant programs ^[2], though much of this rests on in vitro and database work.

What is the difference between GHK and GHK-Cu?

GHK is the free tripeptide (MW 340.38); GHK-Cu is its copper(II) chelate (MW 402.92). Copper coordination is required for most documented tissue-repair activities — the free peptide does not reproduce MMP-2 stimulation in fibroblasts ^[1]. Many neuro studies use free GHK, so the form used in a given study matters.

What does a copper peptide do for your skin?

GHK-Cu stimulates synthesis of collagen, dermatan and chondroitin sulfate, and the proteoglycan decorin; reviewed placebo-controlled trials report improved skin density, firmness, fine lines, and wrinkle depth ^[3]. Copper applied as the tripeptide forms a measurable dermal depot of about 97 ug/cm^2 over 48 hours ^[5].

Does GHK-Cu actually increase collagen production?

In human fibroblast cultures GHK-Cu stimulated collagen synthesis beginning at 10^-12 to 10^-11 M and peaking near 10^-9 M, independent of any change in cell number — a specific metabolic effect ^[1]. A 2025 review reports procollagen synthesis rose in 70% of GHK-Cu-treated subjects versus 50% for vitamin C and 40% for retinoic acid ^[9].

Do copper peptides stimulate hair growth?

Tissue-remodeling reviews report GHK-Cu raises VEGF in dermal fibroblasts and stimulates microvascular angiogenesis and follicular matrix turnover ^[6]; the strongest controlled human signal is the 45-patient ALAVAX hair-count trial ^[4]. Most supporting follicle data is preclinical, and the one human trial used a 5-ALA + GHK combination rather than pure GHK-Cu.

Does copper peptide regrow hair?

In the 6-month ALAVAX (5-ALA + GHK) trial, hair count rose by 52.6 (100 mg/mL) and 71.5 (50 mg/mL) versus 9.6 for placebo (p<0.05), with no adverse events ^[4]. This was a combination formulation, not pure GHK-Cu, so the result is a strong but qualified signal.

Does copper peptide work for hair growth?

The controlled human evidence (the ALAVAX RCT) and preclinical angiogenic and anagen data point to a follicle-supportive effect ^[4][6], but no large randomized trial of pure GHK-Cu for hair growth has been published; the literature is best read as promising and incomplete.

How long does GHK-Cu take to regrow hair?

The pivotal human hair-count study measured outcomes over 6 months ^[4]. Community-reported timelines often cite a few months for visible change, but no validated human timeline for pure GHK-Cu exists, and hair-cycle phases vary considerably between individuals, so any single timeline is an approximation rather than a documented result.

Is copper a DHT blocker?

GHK-Cu is not established as a 5-alpha-reductase or DHT inhibitor. Its hair-supportive effects in the research operate through separate, non-androgenic mechanisms — VEGF/FGF-2-driven follicle angiogenesis, dermal-papilla support, and anagen-phase extension — rather than hormone blockade ^[6]. That makes it mechanistically distinct from the androgen-targeting approaches that dominate hair-loss research.

What are the downsides of copper peptides?

Key caveats: no approved therapeutic indication; most evidence is in vitro or rodent; localized hyperpigmentation has been reported with some topical copper-peptide use; a CO2-laser post-procedure RCT (n=13) found no objective benefit; and vitamin C or low-pH actives can destabilize the complex ^[3][9]. Community systemic dosing protocols have no peer-reviewed basis ^[16].

How long does it take GHK-Cu to tighten skin?

Reviewed topical trials report texture changes over weeks and firmness changes over roughly two to three months, consistent with the timescale of collagen turnover ^[3]. These are research observations, not a guaranteed outcome, and they depend heavily on formulation and delivery ^[5].

Is GHK-Cu better than retinol?

In reviewed comparisons, topical GHK-Cu increased procollagen in 70% of subjects versus 40% for retinoic acid, but the two act differently and the comparison comes from small studies ^[9]. GHK-Cu is generally lower-irritation; this is a research finding, not a clinical recommendation.

What shouldn't be mixed with GHK-Cu?

Strong reducing agents and low-pH actives — notably ascorbic acid (vitamin C) below about pH 3.5, plus AHAs and BHAs — can reduce the Cu(II) ion or compete for copper and break the complex ^[7]. The complex is most stable near pH 5-6.5 at a 1:1 copper-to-peptide ratio ^[7].

Does GHK-Cu affect inflammation?

Tissue-remodeling reviews report GHK-Cu suppresses TGF-beta-1, TNF-alpha, and free-radical activity while chemoattracting repair cells, consistent with NF-kB suppression and Nrf2 antioxidant activation ^[6]. The anti-inflammatory data is drawn from in vitro and rodent models, not controlled human trials, so it is read here as mechanism rather than a demonstrated clinical effect.

Is GHK-Cu safe for long-term use?

Topical Copper Tripeptide-1 has a long cosmetic safety record, but there is a theoretical copper-accumulation and copper-zinc-balance concern with prolonged systemic use and no long-term human safety data for injectable or systemic GHK-Cu. The high copper stability constant (log K approximately 16.4) limits free-copper release ^[7].

Can GHK-Cu help with wound healing?

Across rodent and biomaterial models GHK-Cu accelerates wound closure by upregulating VEGF, FGF-2, and matrix proteins, suppressing free radicals and inflammation, and chemoattracting repair cells ^[6]; a biotinylated-GHK collagen matrix accelerated dermal wound healing in rats ^[12]. The human wound-healing evidence is still early.

What genes does GHK-Cu affect?

Connectivity Map analyses report GHK alters about 31.2% of human genes at a 50%-or-greater change threshold (59% up, 41% down), strongly upregulating the ubiquitin-proteasome system (41 genes up, 1 down) and DNA-repair and antioxidant sets ^[2]. The often-quoted "~4,000 genes" figure is an extrapolation.